The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9101634 B1

PDF
Full Text
Expired
Date of Patent:
Aug. 11, 2015

Filed:

May. 10, 2011
Applicants:

Junying Miao, JiNan, CN;

Baoxiang Zhao, JiNan, CN;

Shangli Zhang, JiNan, CN;

Jing Zhao, JiNan, CN;

Le Su, JiNan, CN;

Lei Han, JiNan, CN;

Inventors:

Junying Miao, JiNan, CN;

Baoxiang Zhao, JiNan, CN;

Shangli Zhang, JiNan, CN;

Jing Zhao, JiNan, CN;

Le Su, JiNan, CN;

Lei Han, JiNan, CN;

Assignee:

SHANDONG UNIVERSITY, Jinan, CN;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/538 (2006.01);
U.S. Cl.
CPC ...
A61K 31/538 (2013.01);
Abstract

An application of 2,3-dihydro-3 hydroxymethyl-6-amino-[1,4]-benzoxazine in the preparation of drugs inducing embryonic stem cells to differentiate to vascular endothelial cells, wherein the concentration of the 2,3-dihydro-3 hydroxymethyl-6-amino-[1,4]-benzoxazine in the preparation of drugs effectively inducing mouse embryonic stem cells to differentiate to vascular endothelial cells is 1˜20 μM. The 2,3-dihydro-3 hydroxymethyl-6-amino-[1,4]-benzoxazine provided by the invention lays foundation for preparing and developing drugs inducing embryonic stem cells to differentiate to vascular endothelial cells, can be used as an effective research tool of embryonic stem cells, and can be used for researching on embryonic stem cell differentiation and new molecular mechanisms of blood vessel formation.


Find Patent Forward Citations

Miao, Junying. (2015). Application of 2, 3-dihydro-3-hydroxymethyl-6-amino-[1,4]-benzoxazine in preparation of drugs inducing embryonic stem cells to differentiate to vascular endothelial cells (U.S. Patent No. 9101634). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9101634

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…